MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 161 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,446,971 | +127.7% | 71,535 | +260.1% | 0.08% | +107.7% |
Q2 2023 | $4,588,815 | -38.5% | 19,865 | -77.9% | 0.04% | -45.1% |
Q1 2023 | $7,457,332 | +44.9% | 89,804 | +39.0% | 0.07% | +65.1% |
Q4 2022 | $5,145,150 | -2.5% | 64,600 | -60.6% | 0.04% | -2.3% |
Q3 2022 | $5,277,000 | +496.9% | 164,036 | +1228.5% | 0.04% | +388.9% |
Q2 2022 | $884,000 | +17.2% | 12,347 | +38.7% | 0.01% | +28.6% |
Q4 2021 | $754,000 | +62.9% | 8,905 | +53.5% | 0.01% | +40.0% |
Q3 2021 | $463,000 | -23.3% | 5,800 | -6.5% | 0.01% | -16.7% |
Q2 2021 | $604,000 | -83.0% | 6,200 | -79.6% | 0.01% | -86.0% |
Q1 2021 | $3,562,000 | +360.8% | 30,454 | +368.0% | 0.04% | +186.7% |
Q3 2020 | $773,000 | -56.7% | 6,507 | -58.7% | 0.02% | -37.5% |
Q2 2020 | $1,786,000 | +237.6% | 15,770 | +99.1% | 0.02% | -27.3% |
Q1 2020 | $529,000 | +56.5% | 7,921 | +193.4% | 0.03% | +175.0% |
Q1 2019 | $338,000 | -90.3% | 2,700 | -91.3% | 0.01% | -91.0% |
Q4 2018 | $3,483,000 | -72.8% | 30,900 | -48.4% | 0.13% | -76.5% |
Q3 2018 | $12,827,000 | +677.4% | 59,900 | +915.3% | 0.57% | +540.4% |
Q2 2018 | $1,650,000 | +272.5% | 5,900 | +55.6% | 0.09% | +169.7% |
Q1 2018 | $443,000 | – | 3,792 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |